Search results :

CAS 76420-72-9

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8
Dizziness 7.9% 0.6% - 4.3% x x x x x x
Alopecia postmarketing x x x x x x x x
Anorexia postmarketing x x x x x x x x
Anosmia postmarketing x x x x x x x x
Arthralgia postmarketing x x x x x x x x
Arthritis postmarketing x x x x x x x x
Asthma postmarketing x x x x x x x x
Ataxia postmarketing x x x x x x x x
Atrial fibrillation postmarketing x x x x x x x
Bronchospasm postmarketing x x x x x x x x
Confusional state postmarketing x x x x x x x x
Conjunctivitis postmarketing x x x x x x x x
Constipation postmarketing x x x x x x x x
Depression postmarketing x x x x x x x x
Dermatitis exfoliative postmarketing x x x x x x x x
Dysgeusia postmarketing x x x x x x x x
Dyspepsia postmarketing x x x x x x x x
Eosinophilia postmarketing x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x
Body temperature increased postmarketing x x x x x x x x
Flank pain postmarketing x x x x x x x x
Flushing postmarketing x x x x x x x x
Glossitis postmarketing x x x x x x x x
Gynaecomastia postmarketing x x x x x x x x
Cardiac arrest postmarketing x x x x x x x
Cardiac failure postmarketing x
Herpes zoster postmarketing x x x x x x x x
Hoarseness postmarketing x x x x x x x x
Hypertension postmarketing x
Hypotension postmarketing 0.6% x
Infarction postmarketing x x x x x x x
Leukocytosis postmarketing x x x x x x x x
Melaena postmarketing x x x x x x x x
Cramp muscle postmarketing x x x x x x x x
Myocardial infarction postmarketing 1.8% x
Myositis postmarketing x x x x x x x x
Nervousness postmarketing x x x x x x x x
Neutropenia postmarketing x x x x x x x x
Palpitations postmarketing x x x x x x x
Pancreatitis postmarketing x x x x x x x x
Paraesthesia postmarketing x x x x x x x x
Pemphigus postmarketing x x x x x x x x
Neuropathy peripheral postmarketing x x x x x x x x
Pruritus postmarketing x x x x x x x x
Pulmonary oedema postmarketing x x x x x x x
Pulmonary embolism postmarketing x x x x x x x
Pulmonary eosinophilia postmarketing x x x x x x x x
Serositis postmarketing x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x
Stomatitis postmarketing x x x x x x x x
Cerebrovascular accident postmarketing x x x x x x x
Thrombocytopenia postmarketing x x x x x x x x
Tinnitus postmarketing x x x x x x x x
Upper respiratory tract infection postmarketing x x x x x x x x
Urticaria postmarketing x x x x x x x x
Vasculitis postmarketing x x x x x x x x
Dry mouth postmarketing x x x x x x x x
Antinuclear antibody positive postmarketing x x x x x x x x
Red blood cell sedimentation rate increased postmarketing x x x x x x x x
Bone marrow depression postmarketing x x x x x x x x
Myalgia postmarketing x x x x x x x x
Lung infiltration postmarketing x x x x x x x x
Erectile dysfunction postmarketing x x x x x x x x
Throat sore postmarketing x x x x x x x x
Dry eye postmarketing x x x x x x x x
Vision blurred postmarketing x x x x x x x x
Photosensitivity postmarketing x x x x x x x x
Dysaesthesia postmarketing x x x x x x x
Lacrimation postmarketing x x x x x x x x
Bradycardia postmarketing x x x x x x x
Atrial tachycardia postmarketing x x x x x x x
Sweating increased postmarketing x x x x x x x x
Insomnia postmarketing x x x x x x x x
Ileus postmarketing x x x x x x x x
Rhinorrhoea postmarketing x x x x x x x
Somnolence postmarketing x x x x x x x x
Abdominal pain 2.1% x x x x x x
Anaemia x x x x x x x
Haemolytic anaemia x x x x x x x
Angina pectoris 1.8% x x x x x x
Angioedema x x x x
Asthenia 0.3% - 0.9% x x x x x x x
Bronchitis 0.9% x x x x x x
Chest pain 2.1% x x x x x x
Cough 0.6% - 0.9% x x x x x x x x
Diarrhoea 1.2% - 1.7% x x x x x x
Dyspnoea 0.4% x x x x x x
Rash 0.4% - 2.4% x x x x x x x x
Fatigue 1.8% - 2.6% x x x x x x x
Headache 0.9% - 9.1% x x x x x x
Hepatitis x x x x x x x
Hyperkalaemia x x x x x x x
Hyponatraemia x x x x x x x
Orthostatic hypotension 0.3% x x x x x x
Jaundice cholestatic x x x x x x x
Laryngeal oedema x x x x x x x
Nausea 0.6% - 1.7% x x x x x x
Oliguria x x x x x x x
Pneumonia 2.4% x x x x x x
Renal failure x x x x x x x
Syncope 0.9% x x x x x x x
Urinary tract infection 2.4% x x x x x x
Vertigo 1.2% x x x x x x
Vomiting 0.9% x x x x x x
Essential hypertension x x x x x x x
Hepatic failure x x x x x x x x
Blood urea increased x x x x x x x
Anaphylactoid reaction x x x x x x x
Renal impairment x
Coronary artery disease x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ENALAPRILAT ANHYDROUS

Side effects:83
Source:FDA Structured Product Label

ENALAPRILAT ANHYDROUS

Side effects:79
Source:FDA Structured Product Label

enalaprilat

Side effects:104
Source:FDA Structured Product Label

ENALAPRILAT

Side effects:104
Source:FDA Structured Product Label

ENALAPRILAT ANHYDROUS

Side effects:104
Source:FDA Structured Product Label

Enalaprilat Anhydrous

Side effects:105
Source:FDA Structured Product Label

ENALAPRILAT

Side effects:105
Source:FDA Structured Product Label

ENALAPRILAT ANHYDROUS

Side effects:106
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label